Focus on Female Cancers


  • In the past 30 years, the use of the Pap test has successfully reduced cervical cancer deaths by nearly 74 percent. However, new technologies like HPV DNA testing, the introduction of new guidelines and the medical liability climate has created challenges in the screening and diagnosis of cervical cancer.
  • While only a small percentage of breast and ovarian cancer diagnoses are associated with inherited mutations in cancer susceptibility genes, it is important for health care practitioners to be able to identify individuals at risk for hereditary cancers, as these individuals are at increased risk for multiple primary cancers as well as early age onset.
  • It is widely understood that the detection of early-stage ovarian cancer results in improved survival. Currently, there is no effective strategy for ovarian cancer screening. Women with persistent and progressive symptoms, such as an increase in bloating, pelvic or abdominal pain, or difficulty eating or feeling full quickly, should be evaluated, with ovarian cancer being included in the differential diagnosis.
  • The challenge of maintaining effective lifelong surveillance for cancer survivors has become a new and increasingly frequent responsibility of women’s health care providers. In order to maximize the overall health and quality of life for these patients, a thorough understanding of cancer survivorship and oncology follow-up care is needed.


Hereditary Cancer Risk Assessment   Ovarian Cancer
Cervical Cancer   Colorectal Cancer
Cancer Survivorship
  Additional Cancer and Women's Resources




American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188